239 related articles for article (PubMed ID: 21421465)
1. Alternate PAX3 and PAX7 C-terminal isoforms in myogenic differentiation and sarcomagenesis.
Charytonowicz E; Matushansky I; Castillo-Martin M; Hricik T; Cordon-Cardo C; Ziman M
Clin Transl Oncol; 2011 Mar; 13(3):194-203. PubMed ID: 21421465
[TBL] [Abstract][Full Text] [Related]
2. Alveolar rhabdomyosarcoma-associated proteins PAX3/FOXO1A and PAX7/FOXO1A suppress the transcriptional activity of MyoD-target genes in muscle stem cells.
Calhabeu F; Hayashi S; Morgan JE; Relaix F; Zammit PS
Oncogene; 2013 Jan; 32(5):651-62. PubMed ID: 22710712
[TBL] [Abstract][Full Text] [Related]
3. Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations.
Ren YX; Finckenstein FG; Abdueva DA; Shahbazian V; Chung B; Weinberg KI; Triche TJ; Shimada H; Anderson MJ
Cancer Res; 2008 Aug; 68(16):6587-97. PubMed ID: 18701482
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of alternatively spliced forms of PAX3, PAX7, PAX3-FKHR and PAX7-FKHR with distinct DNA binding and transactivation properties in rhabdomyosarcoma.
Du S; Lawrence EJ; Strzelecki D; Rajput P; Xia SJ; Gottesman DM; Barr FG
Int J Cancer; 2005 May; 115(1):85-92. PubMed ID: 15688409
[TBL] [Abstract][Full Text] [Related]
5. Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions.
Barr FG; Qualman SJ; Macris MH; Melnyk N; Lawlor ER; Strzelecki DM; Triche TJ; Bridge JA; Sorensen PH
Cancer Res; 2002 Aug; 62(16):4704-10. PubMed ID: 12183429
[TBL] [Abstract][Full Text] [Related]
6. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
Barr FG
Oncogene; 2001 Sep; 20(40):5736-46. PubMed ID: 11607823
[TBL] [Abstract][Full Text] [Related]
7. Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell?
Charytonowicz E; Cordon-Cardo C; Matushansky I; Ziman M
Cancer Lett; 2009 Jul; 279(2):126-36. PubMed ID: 19008039
[TBL] [Abstract][Full Text] [Related]
8. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.
Sorensen PH; Lynch JC; Qualman SJ; Tirabosco R; Lim JF; Maurer HM; Bridge JA; Crist WM; Triche TJ; Barr FG
J Clin Oncol; 2002 Jun; 20(11):2672-9. PubMed ID: 12039929
[TBL] [Abstract][Full Text] [Related]
9. Integrated functions of Pax3 and Pax7 in the regulation of proliferation, cell size and myogenic differentiation.
Collins CA; Gnocchi VF; White RB; Boldrin L; Perez-Ruiz A; Relaix F; Morgan JE; Zammit PS
PLoS One; 2009; 4(2):e4475. PubMed ID: 19221588
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional studies of FKHR-PAX3, a reciprocal fusion gene of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma.
Hu Q; Yuan Y; Wang C
PLoS One; 2013; 8(6):e68065. PubMed ID: 23799156
[TBL] [Abstract][Full Text] [Related]
11. PAX3 and PAX7 exhibit conserved cis-acting transcription repression domains and utilize a common gain of function mechanism in alveolar rhabdomyosarcoma.
Bennicelli JL; Advani S; Schäfer BW; Barr FG
Oncogene; 1999 Jul; 18(30):4348-56. PubMed ID: 10439042
[TBL] [Abstract][Full Text] [Related]
12. Proliferative and apoptotic differences between alveolar rhabdomyosarcoma subtypes: a comparative study of tumors containing PAX3-FKHR or PAX7-FKHR gene fusions.
Collins MH; Zhao H; Womer RB; Barr FG
Med Pediatr Oncol; 2001 Aug; 37(2):83-9. PubMed ID: 11496344
[TBL] [Abstract][Full Text] [Related]
13. PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation.
Charytonowicz E; Matushansky I; Doménech JD; Castillo-Martín M; Ladanyi M; Cordon-Cardo C; Ziman M
Clin Transl Oncol; 2012 Mar; 14(3):197-206. PubMed ID: 22374423
[TBL] [Abstract][Full Text] [Related]
14. Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.
Parham DM; Qualman SJ; Teot L; Barr FG; Morotti R; Sorensen PH; Triche TJ; Meyer WH;
Am J Surg Pathol; 2007 Jun; 31(6):895-901. PubMed ID: 17527077
[TBL] [Abstract][Full Text] [Related]
15. Detection of PAX3-FKHR and PAX7-FKHR fusion transcripts in rhabdomyosarcoma by reverse transcriptase-polymerase chain reaction using paraffin-embedded tissue.
Chen BF; Chen ML; Liang DC; Huang YW; Liu HC; Chen SH
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Feb; 62(2):86-91. PubMed ID: 10063718
[TBL] [Abstract][Full Text] [Related]
16. Expression patterns of FSHD-causing DUX4 and myogenic transcription factors PAX3 and PAX7 are spatially distinct in differentiating human stem cell cultures.
Haynes P; Kernan K; Zhou SL; Miller DG
Skelet Muscle; 2017 Jun; 7(1):13. PubMed ID: 28637492
[TBL] [Abstract][Full Text] [Related]
17. PAX--FKHR fusion genes and AChR-gamma in Chinese patients with rhabdomyosarcoma: diagnosis using formalin-fixed archival tissues.
Chang B; Pang LJ; Qi Y; Liu CX; Cao Y; Li HA; Hu WH; Jiang JF; Zhang WJ; Li F
Int J Surg Pathol; 2009 Feb; 17(1):6-15. PubMed ID: 18988640
[TBL] [Abstract][Full Text] [Related]
18. A Drosophila model of the rhabdomyosarcoma initiator PAX7-FKHR.
Galindo RL; Allport JA; Olson EN
Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13439-44. PubMed ID: 16938866
[TBL] [Abstract][Full Text] [Related]
19. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.
Kelly KM; Womer RB; Sorensen PH; Xiong QB; Barr FG
J Clin Oncol; 1997 May; 15(5):1831-6. PubMed ID: 9164192
[TBL] [Abstract][Full Text] [Related]
20. Pax3-fkhr and pax7-fkhr fusion genes impact outcome of alveolar rhabdomyosarcoma in children.
Kazanowska B; Reich A; Stegmaier S; Békássy AN; Leuschner I; Chybicka A; Koscielniak E
Fetal Pediatr Pathol; 2007; 26(1):17-31. PubMed ID: 17613043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]